Related Experiment Video
Updated: Aug 5, 2026

06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Space Radiation and Cancer Risk in Astronauts: Models, Evidence, Uncertainties, and Emerging Imaging Perspectives
Chiara Zanon1, Michele Basilicata2,3, Agostino Chiaravalloti4,5
1Department of Radiology, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Summary
Estimating cancer risk for astronauts exposed to deep space radiation is challenging. Current models show significant uncertainties, suggesting potential risks may be higher than previously thought.
Area of Science:
- Space medicine
- Radiation oncology
- Astrobiology
Background:
- Astronauts face significant radiation exposure beyond Earth's magnetosphere.
- Galactic cosmic rays and solar particle events pose cancer risks.
- Accurate cancer risk estimation is crucial for long-duration space missions.
Purpose of the Study:
- To review quantitative models for astronaut cancer risk assessment.
- To compare historical and current risk estimations.
- To identify uncertainties and future directions in space radiation risk modeling.
Main Methods:
- Narrative review of quantitative models.
- Analysis of particle fluence-based cross-sections, mixture models, and REID frameworks.
- Examination of uncertainty distribution and ensemble modeling approaches.
Main Results:
- Early models estimated 1-year excess cancer mortality at 1.1-1.3%.
- Later models project lifetime cancer incidence between 2.20-2.98% per Sievert.
- Current NASA standards use a 600 mSv career dose limit, but recent models suggest higher risks.
Conclusions:
- Substantial uncertainties persist in high-LET radiobiology and mixed-field exposures.
- Space exploration mission risks may be underestimated.
- Further research and validated biomarkers are needed for accurate astronaut cancer risk assessment.
Related Concept Videos
Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
X-ray Imaging
German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with X-rays, and by 1900, X-ray was widely...
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
